Article Details

UK's MHRA Grants Early Access to AstraZeneca's Tagrisso as Adjuvant NSCLC Treatment

Retrieved on: 2021-05-07 15:33:45

Tags for this article:

Click the tags to see associated articles and topics

UK's MHRA Grants Early Access to AstraZeneca's Tagrisso as Adjuvant NSCLC Treatment. View article details on hiswai:

Excerpt

NEW YORK – The UK's Medicines and Healthcare products Regulatory Agency (MHRA) on Friday authorized osimertinib (AstraZeneca's Tagrisso) as ...

Article found on: www.precisiononcologynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up